Oral Peptide Drug Delivery: Strategies to Overcome Challenges

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-10-17

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1002/9783527636730.CH3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Converging toward a common speech code: imitative and perceptuo-motor recalibration processes in speech production

  2013cited by this paper
• Protein aggregation--pathways and influencing factors.

  2010cited by this paper
• Transporter targeted drug delivery

  2010cited by this paper
• Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.

  2010cited by this paper
• Protein delivery: from conventional drug delivery carriers to polymeric nanoreactors

  2010cited by this paper
• Cell penetrating peptides: overview and applications to the delivery of oligonucleotides

  2010cited by this paper
• Effect of sinomenine on the in vitro intestinal epithelial transport of selected compounds

  2009cited by this paper
• PEG-modified biopharmaceuticals

  2009cited by this paper
• Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.

  2009cited by this paper
• Therapeutic application of peptides and proteins: parenteral forever?

  2009cited by this paper
• Molecular Aspects of Mucoadhesive Carrier Development for Drug Delivery and Improved Absorption

  2009cited by this paper
• Tight junction modulator and drug delivery

  2009cited by this paper
• Intestinal Drug Transport Enhancement by Aloe vera

  2009cited by this paper
• Engineering strategies to enhance nanoparticle-mediated oral delivery

  2008cited by this paper
• Discovery of tight junction modulators: significance for drug development and delivery.

  2008cited by this paper
• Protein and Peptide Drug Delivery: Oral Approaches

  2008cited by this paper
• Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery

  2008cited by this paper
• Past, present, and future technologies for oral delivery of therapeutic proteins.

  2008cited by this paper
• Professor William I. Higuchi: teacher and scientist.

  2008cited by this paper
• Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations

  2008cited by this paper
• Developments in polymeric devices for oral insulin delivery

  2008cited by this paper
• Increased paracellular absorption by bile salts and P-glycoprotein stimulated efflux of otilonium bromide in Caco-2 cells monolayers as a model of intestinal barrier.

  2008cited by this paper
• Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives

  2007cited by this paper
• Cell Penetrating Peptides: How Do They Do It?

  2007cited by this paper
• Nanoparticle Drug Delivery Platform

  2007cited by this paper
• Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps

  2007cited by this paper
• Azo compounds in colon-specific drug delivery

  2007cited by this paper
• Polymer-drug conjugates: Progress in polymeric prodrugs

  2006cited by this paper
• Tight junction modulation and its relationship to drug delivery.

  2006cited by this paper
• Issues related to targeted delivery of proteins and peptides

  2006cited by this paper
• POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS

  2006cited by this paper
• Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.

  2006cited by this paper
• Novel delivery technologies for protein and peptide therapeutics.

  2006cited by this paper
• Disruption of Epithelial Tight Junctions by Yeast Enhances the Paracellular Delivery of a Model Protein

  2006cited by this paper
• Mucoadhesive systems in oral drug delivery.

  2005cited by this paper
• Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium.

  2005cited by this paper
• Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.

  2005cited by this paper
• Concept, strategies, and feasibility of noninvasive insulin delivery.

  2004cited by this paper
• Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption.

  2004cited by this paper
• Cell Penetrating Peptides in Drug Delivery

  2004cited by this paper
• Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.

  2004cited by this paper
• Polysaccharides for Colon Targeted Drug Delivery

  2004cited by this paper
• The lectin-cell interaction and its implications to intestinal lectin-mediated drug delivery.

  2004cited by this paper
• The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

  2004cited by this paper
• Nanoscale technology of mucoadhesive interactions.

  2004cited by this paper
• Alternative routes of insulin delivery

  2003cited by this paper
• Bioadhesive microspheres as a controlled drug delivery system.

  2003cited by this paper
• N-Trimethyl Chitosan Chloride: Optimum Degree of Quaternization for Drug Absorption Enhancement Across Epithelial Cells

  2003cited by this paper
• Enhanced Permeability of Molecular Weight Markers and Poorly Bioavailable Compounds Across Caco-2 Cell Monolayers Using the Absorption Enhancer, Zonula Occludens Toxin

  2002cited by this paper
• Peptide delivery systems

  2001cited by this paper
• Oral drug absorption enhancement by chitosan and its derivatives.

  2001cited by this paper
• The potential use of receptor-mediated endocytosis for oral drug delivery.

  2001cited by this paper
• Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.

  2001cited by this paper
• Intestinal permeation enhancers.

  2000cited by this paper
• Mechanistic Studies on Surfactant-Induced Membrane Permeability Enhancement

  2000cited by this paper
• Enhancing paracellular permeability by modulating epithelial tight junctions.

  2000cited by this paper
• Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments.

  1999cited by this paper
• Oral insulin delivery.

  1999cited by this paper
• Transcellular uptake mechanisms of the intestinal epithelial barrier Part one.

  1999cited by this paper
• Multiplicity of the H+-dependent transport mechanism of dipeptide and anionic beta-lactam antibiotic ceftibuten in rat intestinal brush-border membrane.

  1999cited by this paper
• Vitamin B12-mediated transport of nanoparticles across Caco-2 cells.

  1999cited by this paper
• Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.

  1999cited by this paper
• Optimizing oral absorption of peptides using prodrug strategies.

  1999cited by this paper
• Permeability and absorption of leuprolide from various intestinal regions in rabbits and rats.

  1999cited by this paper
• The effect of physical barriers and properties on the oral absorption of particulates.

  1998cited by this paper
• Novel approaches for oral delivery of macromolecules.

  1998cited by this paper
• The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins.

  1998cited by this paper
• Innovative strategies for the oral delivery of drugs and peptides.

  1998cited by this paper
• The challenge of proteolytic enzymes in intestinal peptide delivery

  1997cited by this paper
• In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement

  1997cited by this paper
• Diffusion of drugs in native and purified gastrointestinal mucus.

  1997cited by this paper
• Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers

  1997cited by this paper
• In vitro permeability of peptidomimetic drugs : the role of polarized efflux pathways as additional barriers to absorption

  1997cited by this paper
• Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies.

  1997cited by this paper
• Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption

  1997cited by this paper
• Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells.

  1997cited by this paper
• Transmembrane transport of peptide type compounds: prospects for oral delivery.

  1996cited by this paper
• Strategies for delivery of peptides utilizing absorption-enhancing agents.

  1996cited by this paper
• The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro

  1996cited by this paper
• Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery

  1996cited by this paper
• Structural requirements for intestinal absorption of peptide drugs

  1996cited by this paper
• Prodrugs of peptides and peptidomimetics for improved formulation and delivery

  1996cited by this paper
• Enhancement of the intestinal absorption of peptides and nonpeptides

  1996cited by this paper
• EXPERIMENTAL ESTIMATION OF THE EFFECTIVE UNSTIRRED WATER LAYER THICKNESS IN THE HUMAN JEJUNUM, AND ITS IMPORTANCE IN ORAL-DRUG ABSORPTION

  1995cited by this paper
• Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugs

  1994cited by this paper
• Intestinal Permeability Enhancement: Efficacy, Acute Local Toxicity, and Reversibility

  1994cited by this paper
• Aqueous acidic degradation of the carbacephalosporin loracarbef.

  1993cited by this paper
• Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.

  1993cited by this paper
• Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100

  1993cited by this paper
• Enhancement of intestinal peptide absorption

  1992cited by this paper
• Peptide and protein drugs: II. Non-parenteral routes of delivery

  1991cited by this paper
• Peptide and protein drugs: I. Therapeutic applications, absorption and parenteral administration

  1991cited by this paper
• Transport of peptide and protein drugs across biological membranes

  1990cited by this paper
• Intestinal drug absorption enhancement: an overview.

  1989cited by this paper
• Penetration and enzymatic barriers to peptide and protein absorption

  1989cited by this paper
• Systemic delivery of therapeutic peptides and proteins

  1988cited by this paper
• Absorption of protein via the intestinal wall. A quantitative model.

  1987cited by this paper
• H+ coupled uphill transport of aminocephalosporins via the dipeptide transport system in rabbit intestinal brush-border membranes.

  1986cited by this paper
• Receptor-mediated transport of IgG

  1984cited by this paper
• Superficial or membrane digestion of peptides in dinitrophenol-inhibited rat small intestine.

  1979cited by this paper

• Mesoporous silica nanoparticles: An emerging approach in overcoming the challenges with oral delivery of proteins and peptides.

  2023cites this paper
• Nanocarriers in Protein and Peptide Drug Delivery

  2021cites this paper
• Protein/Peptide Drug Delivery Systems

  2019cites this paper
• Biotechnology-Based Pharmaceutical Products

  2019cites this paper
• Recent advancements in oral delivery of insulin: from challenges to solutions

  2017cites this paper
• Development of therapeutic proteins: advances and challenges

  2015influential citation
• Strategies for enhanced peptide and protein delivery.

  2013cites this paper
• Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells.

  2013cites this paper